164 related articles for article (PubMed ID: 27182051)
21. Intracellular glutathione regulates Andrographolide-induced cytotoxicity on hepatoma Hep3B cells.
Ji L; Shen K; Liu J; Chen Y; Liu T; Wang Z
Redox Rep; 2009; 14(4):176-84. PubMed ID: 19695125
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
[TBL] [Abstract][Full Text] [Related]
23. Anti-miR-21 Suppresses Hepatocellular Carcinoma Growth via Broad Transcriptional Network Deregulation.
Wagenaar TR; Zabludoff S; Ahn SM; Allerson C; Arlt H; Baffa R; Cao H; Davis S; Garcia-Echeverria C; Gaur R; Huang SM; Jiang L; Kim D; Metz-Weidmann C; Pavlicek A; Pollard J; Reeves J; Rocnik JL; Scheidler S; Shi C; Sun F; Tolstykh T; Weber W; Winter C; Yu E; Yu Q; Zheng G; Wiederschain D
Mol Cancer Res; 2015 Jun; 13(6):1009-21. PubMed ID: 25758165
[TBL] [Abstract][Full Text] [Related]
24. Mistletoe extract Fraxini inhibits the proliferation of liver cancer by down-regulating c-Myc expression.
Yang P; Jiang Y; Pan Y; Ding X; Rhea P; Ding J; Hawke DH; Felsher D; Narla G; Lu Z; Lee RT
Sci Rep; 2019 Apr; 9(1):6428. PubMed ID: 31015523
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.
Xu Y; Huang J; Ma L; Shan J; Shen J; Yang Z; Liu L; Luo Y; Yao C; Qian C
Cancer Lett; 2016 Feb; 371(2):171-81. PubMed ID: 26655273
[TBL] [Abstract][Full Text] [Related]
26. [Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes].
Fu XY; Tan DM; Hou ZH; Hu ZL; Liu GZ; Ouyang Y; Liu F
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):598-604. PubMed ID: 23207154
[TBL] [Abstract][Full Text] [Related]
27. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
Kim JK; Noh JH; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Shen Q; Park WS; Lee JY; Borlak J; Nam SW
Hepatology; 2013 Mar; 57(3):1055-67. PubMed ID: 23079745
[TBL] [Abstract][Full Text] [Related]
28. In vivo inhibitory activity of andrographolide derivative ADN-9 against liver cancer and its mechanisms involved in inhibition of tumor angiogenesis.
Yang W; Zhao J; Wang Y; Xu H; Wu Z; Hu Y; Jiang K; Shen P; Ma C; Guan Z; Zhang Y; Ma J; Shang N; Yan G; Wang Z; Dai G
Toxicol Appl Pharmacol; 2017 Jul; 327():1-12. PubMed ID: 28438631
[TBL] [Abstract][Full Text] [Related]
29. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
[TBL] [Abstract][Full Text] [Related]
30. Identification of MicroRNAs Involved in Growth Arrest and Apoptosis in Hydrogen Peroxide-Treated Human Hepatocellular Carcinoma Cell Line HepG2.
Luo Y; Wen X; Wang L; Gao J; Wang Z; Zhang C; Zhang P; Lu C; Duan L; Tian Y
Oxid Med Cell Longev; 2016; 2016():7530853. PubMed ID: 27597883
[TBL] [Abstract][Full Text] [Related]
31. Bioinformatic analysis of microRNA networks following the activation of the constitutive androstane receptor (CAR) in mouse liver.
Hao R; Su S; Wan Y; Shen F; Niu B; Coslo DM; Albert I; Han X; Omiecinski CJ
Biochim Biophys Acta; 2016 Sep; 1859(9):1228-1237. PubMed ID: 27080131
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
[TBL] [Abstract][Full Text] [Related]
33. Andrographolide enhances 5-fluorouracil-induced apoptosis via caspase-8-dependent mitochondrial pathway involving p53 participation in hepatocellular carcinoma (SMMC-7721) cells.
Yang L; Wu D; Luo K; Wu S; Wu P
Cancer Lett; 2009 Apr; 276(2):180-8. PubMed ID: 19097688
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma.
Tsai WC; Hsu PW; Lai TC; Chau GY; Lin CW; Chen CM; Lin CD; Liao YL; Wang JL; Chau YP; Hsu MT; Hsiao M; Huang HD; Tsou AP
Hepatology; 2009 May; 49(5):1571-82. PubMed ID: 19296470
[TBL] [Abstract][Full Text] [Related]
35. Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes.
Yang Y; Yang L; You QD; Nie FF; Gu HY; Zhao L; Wang XT; Guo QL
Cancer Lett; 2007 Oct; 256(2):259-66. PubMed ID: 17693016
[TBL] [Abstract][Full Text] [Related]
36. Identification of MicroRNAs and target genes involvement in hepatocellular carcinoma with microarray data.
Wang D; Tan J; Xu Y; Tan X; Han M; Tu Y; Zhu Z; Zen J; Dou C; Cai S
Hepatogastroenterology; 2015; 62(138):378-82. PubMed ID: 25916067
[TBL] [Abstract][Full Text] [Related]
37. Andrographolide sensitizes the cytotoxicity of human colorectal carcinoma cells toward cisplatin via enhancing apoptosis pathways in vitro and in vivo.
Lin HH; Shi MD; Tseng HC; Chen JH
Toxicol Sci; 2014 May; 139(1):108-20. PubMed ID: 24563380
[TBL] [Abstract][Full Text] [Related]
38. [Roles of miR-590-5p and miR-590-3p in the development of hepatocellular carcinoma].
Yang H; Zheng W; Zhao W; Guan C; An J
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):804-11. PubMed ID: 23803188
[TBL] [Abstract][Full Text] [Related]
39. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.
Braza-Boïls A; Salloum-Asfar S; Marí-Alexandre J; Arroyo AB; González-Conejero R; Barceló-Molina M; García-Oms J; Vicente V; Estellés A; Gilabert-Estellés J; Martínez C
Hum Reprod; 2015 Oct; 30(10):2292-302. PubMed ID: 26307093
[TBL] [Abstract][Full Text] [Related]
40. Andrographolide impedes cancer stemness and enhances radio-sensitivity in oral carcinomas via miR-218 activation.
Yang PY; Hsieh PL; Wang TH; Yu CC; Lu MY; Liao YW; Lee TH; Peng CY
Oncotarget; 2017 Jan; 8(3):4196-4207. PubMed ID: 27926533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
